Key factors
sym | JNJ |
exch | US |
MCap | 351.20B |
Beta | 0.528 |
PE Ratio | 19.61 |
EPS | 7.43 |
Div | 4.76 |
Div Yld | 3.400 |
Div date | 2024-05-20 |
Yesterday
sym | JNJ |
exch | US |
close | 149.56 |
50 Day MA | 156.31 |
200 Day MA | 158.54 |
52 Week High | 173.31 |
52 Week Low | 143.13 |
Target Price | 164.19 |
Market Cap Mln | 351.20K |
Share statistics
Shares Outstanding | 2.409B |
Shares Float | 2.404B |
Percent Institutions | 71.21 |
PercentInsiders | 0.09 |
SharesShort | 15.94M |
Short Ratio | 2.24 |
Shares Short Prior Month | 14.85M |
Short Percent | 0.659 |
Income
Revenue TTM | 85.64B |
Revenue Per Share TTM | 34.40 |
Quarterly Revenue Growth YOY | -13.6 |
Gross Profit TTM | 63.95B |
EBITDA | 30.67B |
Diluted Eps TTM | 7.43 |
Quarterly Earnings Growth YOY | 10.59 |
earning
Operating Margin TTM | 0.288 |
PEGRatio | 0.887 |
Trailing PE | 19.61 |
EPS Estimate Current Quarter | 2.28 |
EPS Estimate Current Year | 10.02 |
EPS Estimate Next Quarter | 2.61 |
EPS Estimate Next Year | 10.34 |
Earnings Share | 7.43 |
Dividend
Forward Annual Dividend Rate | 4.96 |
Forward Annual Dividend Yield | 3.400 |
Payout Ratio | 36.66 |
Dividend Date | 2024-06-04 |
Last Split Date | 2001-06-13 |
Last Split Factor | 2:1 |
business
Enterprise Value Ebitda | 15.51 |
Enterprise Value Revenue | 4.249 |
Book Value /share | 28.57 |
Price Book MRQ | 5.169 |
Price Sales TTM | 4.174 |
ProfitMargin | 0.473 |
ReturnOnAssetsTTM | 0.083 |
ReturnOnEquityTTM | 0.183 |
Sector
Gic Group | Pharmaceuticals, Biotechnology & Life Sciences |
Gic Industry | Pharmaceuticals |
Gic Sector | Health Care |
Gic Sub Industry | Pharmaceuticals |
Industry | Drug Manufacturers - General |
Sector | Healthcare |
Codes
ISIN | US4781601046 |
CIK | 200406 |
Code | JNJ |
CUSIP | 478160104 |
Employer Id Number | 22-1024240 |
CountryISO | US |
Currency Code | USD |
Currency Name | US Dollar |
Exchange | NYSE |
Currency Symbol | $ |
fund
Type | Common Stock |
UpdatedAt | 2024-04-19 |
Home Category | Domestic |
info
Fiscal Year End | December |
ForwardPE | 13.85 |
Full Time Employees | 131.9K |
IPODate | 1944-09-24 |
International Domestic | International Domestic |
MostRecent Quarter | 2023-12-31 |
Contact
Name | Johnson & Johnson |
Address | One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933 |
Country Name | USA |
Phone | 732 524 0400 |
Web URL | https://www.jnj.com |
Logo URL | /img/logos/US/JNJ.png |
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.